CRESCENT BIOPHARMA, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
CRESCENT BIOPHARMA, INC. (CBIO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $6.70 million as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2025-02-13
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $6.70M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $7.32M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $7.25M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $7.10M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2024-12-31 | $6.70M 10-K · filed 2025-02-13 |
| 2023-12-31 | $7.32M 10-K · filed 2025-02-13 |
| 2022-12-31 | $7.25M 10-K · filed 2024-03-27 |
| 2021-12-31 | $7.10M 10-K · filed 2023-03-29 |
| 2020-12-31 | $6.78M 10-K · filed 2022-03-03 |
| 2019-12-31 | $4.94M 10-K · filed 2021-03-02 |
| 2018-12-31 | $3.29M 10-K · filed 2020-02-28 |
| 2017-12-31 | $2.27M 10-K · filed 2019-03-06 |
| 2016-12-31 | $2.11M 10-K · filed 2018-03-06 |
| 2015-12-31 | $1.21M 10-K · filed 2017-03-01 |
| 2014-12-31 | $559.47K 10-K · filed 2016-02-29 |
| 2013-12-31 | $24.15K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |